Effects of Efonidipine Hydrochloride on Heart Rate and Circulatory Changes Due to Stress

References

• Tanaka H, Shigenobu K. Efonidipine hydrochloride: A dual blocker of L- and T-type Ca2+ channels. Cardiovasc Drug Rev. 2002; 20: 81–92
   PubMedGoogle Scholar
• Hagiwara N, Irisawa H, Kameyama M. Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Physiol. 1998; 395: 233–253
   Google Scholar
• Shimizu M, Ogawa K, Sasaki H, Uehara Y, Otsuka Y, Okumura H, Kusaka M, Hasuda T, Yamada T, Mochizuki S. Effect of efonidipine, an L- and T-type dual calcium channel blocker, on heart rate and blood pressure in patients with mild to severe hypertension: An uncontrolled, open-label pilot study. Current Ther Res. 2003; 64: 707–714
   PubMed Web of Science ®Google Scholar
• Gillman MW, Kannel WB, Belanger A, D'Agostino RB. Influence of heart rate on mortality among persons with hypertension: The Framingham Study. Am Heart J 1993; 125: 1148–1154
   PubMed Web of Science ®Google Scholar
• Wittert GA, Or HK, Livesey JH, Richards AM, Donald RA, Espiner EA. Vasopressin, corticotrophin-releasing factor, and pituitary adrenal responses to acute cold stress in normal humans. J Clin Endocrinol Metab. 1992; 75: 750–755
   PubMed Web of Science ®Google Scholar
• Ng AV, Callister R, Johnson DG, De Seals. Sympathetic neural reactivity to stress does not increase with age in healthy humans. Am J Physiol. 1994; 267: H344–H353
   PubMed Web of Science ®Google Scholar
• Delarue J, Matzinger O, Binnert C, al et. Fish oil prevents the adrenal activation elicited by mental stress in healthy men. Diabetes Metab. 2003; 29: 289–295
   PubMed Web of Science ®Google Scholar
• Nakashima M, Kanamaru M, Uematsu T, Sato R, Mizuno A, Nagashima S, Takiguchi S, Tanaka S, Hibi M, Saito T, Yoshida Y. Pharmacokinetics and safety of NZ-105 in healthy volunteers: single-dose and multiple-dose studies. Jpn J Clin Pharmacol Ther. 1991; 22: 673–683
   Google Scholar
• Thomas F, Bean K, Provost JC, Guize L, Benetos A. Combined effects of heart rate and pulse pressure on cardiovascular mortality according to age. J Hypertens. 2001; 19: 863–869
   PubMed Web of Science ®Google Scholar
• Harada K, Nomura M, Nishikado A, Uehara K, Nakaya Y, Ito S. Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities. Examination using spectral analysis of heart rate/blood pressure variabilities and 123I-metaiodobenzylguanidine myocardial scintigraphy. Circ J. 2003; 67: 139–145
   PubMed Web of Science ®Google Scholar
• Tseng GN, Boyden PA. Multiple types of Ca2+ currents in single canine Purkinje cells. Circ Res. 1989; 65: 1735–1750
   PubMed Web of Science ®Google Scholar
• Clozel JP, Ertel EA, Ertel SI. Discovery and main pharmacological properties of mibefradil (Ro40–5967), the first selective T-type calcium channel blocker. J Hypertens. 1997; 15(suppl 5)S17–S25
   Google Scholar
• Tzivoni D, Kadr H, Braat S, Rutsch W, Ramires JA, Kobrin I. Efficacy of mibefradil compared with amlodipine in suppressing exercise-induced and daily silent ischemia. Circulation 1997; 96: 2557
   PubMed Web of Science ®Google Scholar
• Tanaka H, Masumiya H, Sekine T, Sijuku T, Sugahara M, Taniguchi H, Terada M, Saito W, Shigenobu K. Myocardial and vascular effects of efonidipine in vitro as compared with nifedipine, verapamil and diltiazem. Gen Pharmac. 1996; 27: 451–454
   PubMedGoogle Scholar
• Minami J, Ishimitsu T, Higashi T, Numabe A, Matsuoka H. Comparison between cilnidipine and nisoldipine with respect to effects on blood pressure and heart rate in hypertensive patients. Hypertens Res. 1998; 21: 215–219
   PubMed Web of Science ®Google Scholar
• Morimoto S, Takeda K, Oguni A, Kido H, Harada S, Moriguchi J, Itoh H, Nakata T, Sasaki S, Nakagawa M. Reduction of white coat effect by cilnidipine in essential hypertension. Am J Hypertens. 2001; 14: 1053–1057
   PubMed Web of Science ®Google Scholar
• Pellizer AM, Kamen PK, Esler MD, Lim S, Krum H. Comparative effects of mibefradil and nifedipine gastrointestinal transport system on autonomic function in patients with mild and moderate essential hypertension. J Hypertens. 2001; 19: 279–285
   PubMed Web of Science ®Google Scholar
• Ohashi N, Mitamura H, Tanimoto K, Fukuda Y, Kinebuchi O, Kurita Y, Shiroshita-Takeshita A, Miyoshi S, Hara M, Takatsuki S, Ogawa S. A Comparison between calcium channel blocking drugs with different potencies for T- and L-Type channels in preventing atrial electrical remodeling. J Cardiovasc Pharmacol. 2004; 44: 386–392
   PubMed Web of Science ®Google Scholar
• Clozel JP, Ertel EA, Ertel SI. Voltage-gated T-type Ca2+ channels and heart failure. Proc Assoc Am Physicians 1999; 111: 429–437
   PubMedGoogle Scholar
• Huang B, Qin D, Deng L, Boutjdir M. E1-Sherif N. Reexpression of T-type Ca2+ channel gene and current in post-infarction remodeled rat left ventricle. Cardiovasc Res. 2000; 46: 442–449
   PubMed Web of Science ®Google Scholar